ILO Occupational Cancer Prevention and Control
ILO Occupational Cancer Prevention and Control
ILO Occupational Cancer Prevention and Control
A N D HEALTH
SERIES
No. 3 3
OCCUPATIONAL CANCER -
PREVENTION A N D CONTROL
I N T E R N A T I O N A L L A B O U R OFFICE - G E N E V A
ISBN 92-2-101827-X
The designations employed in ILO publications, which are in conformity with United
Nations practice, and the presentation of material therein do not imply the expression of
any opinion whatsoever on the part of the International Labour Office concerning the
legal status of any country or territory or of its authorities, or concerning the delimitation
of its frontiers.
The responsibility for opinions expressed in signed articles, studies and other contributions
rests solely with their authors, and publication does not constitute an endorsement by the
International Labour Office of the opinions expressed in them.
ILO publications can be obtained through major booksellers or ILO local offices in many
countries, or direct from ILO Publications, International Labour Office, CH-1211 Geneva 22,
Switzerland. A catalogue or list of new publications will be sent free of charge from
the above address.
£âSÊ
FOREWORD 1
1. PROBLEMS RELATING TO THE ESTABLISHHENT OF
OCCUPATIONAL STANDARDS FOR CARCINOGENS 3
1.1 Animal experimentation 3
1.2 Extrapolation from animal to man 5
1.3 Epidemiological studies 7
1.4 New chemicals and chemicals in use 8
2. CLASSIFICATION OF CARCINOGENS FOR THE PURPOSE OF
LEGISLATION 10
3. PREVENTIVE MEASURES 13
3.1 General principles 13
3.2 Technical measures 14
3.3 Personal protective measures 16
3.4 Emergencies 17
4. EXPOSURE MONITORING 18
4.1 Workplace monitoring 18
4.2 Biological monitoring 19
5. PERSONNEL ADMINISTRATION 21
5.1 Choice of personnel 21
5.2 informing workers .., 21
5.3 Labour turnover 21
5.4 Lists of workers 22
6. MEDICAL SUPERVISION 23
6.1 Special medical examinations 23
6.2 Information to be supplied to the responsible
physician 23
6.3 Assignment to specified workplaces 24
6.4 Personal work logbook 24
7. REGISTERS AND RECORDINGS 25
7.1 Technical files 25
7.2 Medical files 26
APPENDIX 1 •*• Carcinogenic substances and agents 27
Materials of complex composition whose use
represents a significant carcinogenic risk 28
Industrial processes involving significant.
carcinogenic risk 28
E-2700-lTC:8
Pa.qe
APPENDIX 2 - ILO international instruments 29
Convention No. 139 concerning prevention and
control of occupational hazards caused by carcino-
genic substances and agents 29
Recoanendation No. 147 concerning prevention and
control of occupational hazards caused by carcino-
genic substances and agents -....<.. 32
FOREWORD
1
Participated in this consultation (10-12 November 1975): Dr.
E. Bolinder, Chief, dedicai Department, Swedish Trade Onion Con-
federation, Stockholm (Sweden); Dr. B. Holmberg, Associate Professor
of Toxicology, National Board of Occupational Safety and Health,
Stockholm (Sweden); Dr. A. Munn, Division Medical Officer, Imperial
Chemical Industries Ltd., Manchester (united Kingdom); Dr. V.E.
Rose, Department of Health, Education and Welfare, Houston (USA);
Dr. G. Smagghe, Chef des Services de médecine et de toxicologie,
Société de produits chimiques Dgine-Kuhlmánn, Paris (France); Prof.
R. Truhaut, Directeur du centre de recherches toxicologiques,
Faculté des sciences pharmaceutiques et biologiques, Paris (France).
Occupational Cancer.• The ILO expresses its thanks to these persons
for their valuable collaboration. It is hoped that this publication
«ill serve as a useful aid to all those having responsibilities in
the planning and implementation of measures for the prevention of
occupational cancer.
2
1. PROBLEMS RELATING TO THE ESTABLISHMENT
OF OCCtJPATl5NAL~STÏNDÏRDS~POR_CARCÏNOGENS
3
become available. Serious concerns exist as to whether the basic
chemical or the impurity is the aetiological agent. The best
example of this probably involves 1- and 2-naphthylanines. Here the
2-isomer is without doubt a carcinogen. Some researchers have
attributed the increased incidence of bladder cancer among workers
involved in the manufacture of 1-naphthylamine to the 2-impurities.
However, lacking definitive data, certain countries which regulate
carcinogens have chosen to include 1-naphthylamine as a carcinogenic
substance.
1
Bryan, H.R. and Shimkin, S.B. (1943) Journal_of_the_National
Cancer .Institute. 3, 503. - - -
2
Payne, W.U. and Heuper, U.C. (1960) American Industrial
Hygiene association Journal. 21, 3S0. ~
4
1.2 Extrapolation from aninal to nan
The sane problems arise in the extrapolation of laboratory
tests to industrial exposures because of variations in response in
different aninal species and in nan, in respect of both tusour
induction and target organ. The problem is enhanced in so far as in
nost experinents it has not been possible to reproduce industrial
exposure in respect of either dose level or route of entry into the
body.
5
least 2,995 test animals in each dose group. Such a
comparison is based upon the assumption that human populations
and test animal populations respond identically, an assumption
which may well be false.
!afeiÊ_i' fiSfber_of_anina1s_in_toxiçit£
experiments
100 1 1
80 2 3
60 4 6
50 5 7
40 6 10
20 1« 21
10 29 44
5 59 90
2 149 228
1 299 459
0.1 2 995 4 603
0.01 29 956 46 050
Source: Zbinden G. (1973) Progress in Toxicology. 1, Springer, New
ïork.
6
of epidemiological studies and proper animal experiments. In the
absence of an adequate dose-response curve for a human population as
obtained by epidemiological studies, animal data should essentially
be used to establish carcinogenicity as such, and possibly for
comparing the risk potential from one substance to another.
Experimental animal testing remains indeed necessary in the case of
new substances for which epidemiological studies are obviously not
applicable. From a practical point of view, exposure to an
experimental carcinogen should be kept as close to zero as possible
in the occupational environment, irrespective of dose level in the
test system, animal species, tumour site, type or frequency.
7
this mere fact involves an acceptance that an increase in cancer
incidence is reasonable. The conclusion is that a risk estimate
based on an epidemiological study should be corrected by a "safety
factor", the size of which could be 2 or higher. Even if an
occupational standard could tentatively be established according to
such estimations, the exposure should be kept as close to zero as
possible because a zero-effect level might not exist or at least
would be most difficult to validate.
This is the concept which led, for certain carcinogens, to the
establishment of "technical reference concentrations". These were
laid down for practical purposes in order to provide guidance for
the planning and implementation of the technical control of the
working environment. Where these concentration limits were
established they have been primarily based, in a nueber of cases, on
the concept of "least feasibly detectable" or attainable
concentration using existing technology. However, the setting of
occupational standards according to technological criteria must be
made with an understanding of technology's potential for change when
specifically directed towards improving work hygiene. Tbe story of
vinyl chloride exemplifies this situation. The Swedish occupational
exposure limit of vinyl chloride was temporarily lowered in the
spring of 1974 to 20 ppm time-weighted average. This level was
merely an adjustment to the practical level already maintained in
the polymerisation industry at that time. A limit below 10 ppm was
considered technologically not possible by the industry. Animal
data indicated, however, that 50 ppm, which was the lowest dose
tested, induced tumours in mice and rats, a fact which strengthened
the demand for a zero exposure. In the autumn of 1974, 1 ppm was
adopted as the time-weighted standard. Today the Swedish companies
are able to maintain that limit of exposure. The technologically
impossible task of today might thus be feasible tomorrow.
l.i» New_çhemiçals_and_çhemiçals_in_use
A prevention programme for new chemicals could include an
obligatory adeguate testing of chemicals for their possible
carcinogenic potential.
For chemicals already in industrial use, testing for
carcinogenicity and mutagenicity may be required by national
authorities, especially for suspect substances where no
epidemiological data exist or can be obtained.
Although testing would be desirable for all new chemicals and
for a large proportion of chemicals already in use, this is
obviously a most difficult task considering the number of new
substances introduced each year onto the market as well as those
already in use. Moreover, taking into account the relatively long
duration and the complexity of animal experiments, it becomes
necessary to evolve criteria for selecting substances to be
submitted to further animal experiments. Promising avenues in this
connection seem to be provided by testing substances for
mutagenicity in bacteria or other inferior organisms, for malignant
cell transformation in vitro or for unscheduled DNA synthesis.
These methods are more rapid than experimental testing in laboratory
animals and, although they still present considerable difficulties
in their interpretation, substances found to be active in these
tests may also be suspected for carcinogenicity. In spite of
certain differences of opinion in the assessment of the screening
8
tests, the present approach is therefore to carry out tests in
animal systems on chemicals which (a) are found to be active by
screening tests for mutagenicity; and (b) are structurally related
to known experimental or human carcinogens. Other important factors
to be considered when establishing priorities are the physical,
chemical and biochemical properties, especially as they relate to
potential routes of exposure; the quantity of material produced or
the anticipated potential: the number of workers exposed and the
level of exposure; the ultimate community involvement, whether for
instance exposure is limited to industrial settings or a wider
contamination is possible. These problems have been actively
studied in recent years.»
fts a consequence it has been felt necessary to develop
practical guidelines for the conduct of these experimental studies.
it the international level such guidelines have been developed by
the International Agency for Research on Cancer (IARC) and, in
essence, these require: exposure to dose levels lending to
measurable effects; appropriate length of testing; presentation of
a satisfactory protocol involving appropriate exposure routes; use
of an adequate control group; interpretation of results in
relationship to a control group.
In addition to experimental studies and animal testing, epi-
demiological studies should be performed in order to establish a
risk estimate for chemicals in use.
The final evaluation, especially as regards the establishment
of preventive regulatory measures, should consider the carcinogenic
hazard to working populations. Consequently, several factors should
be taken into consideration, among which are: evaluation, both
qualitative and quantitative, of experimental data; critical
evaluation of epidemiological data when available; consideration of
physical, chemical and bio-chemical factors; the nature of the
technology where exposures may result; and other possible
influencing factors, such as synergistic/antagonistic potential, the
potential for personal factors such as diet and smoking to have a
contributory effect and the possibility of mutagenic and/or
teratogenic effects to be manifested, especially where exposure of
females of childbearing age is possible.
» See also:
world Health Organisation (1971) Principles for the testing and
evaluation of drugs for carcinogenicity. Technical Report Series No.
«82, WHO, Geneva.
World Health Organisation (1971) Evaluation and testing of drugs for
mutagenicity: principles and problems. Technical Eeport Series No.
U82, WHO, Geneva.
World Health Organisation (1974) Assessment of the carcinogenicity
and mutagenicity of chemicals. Technical Report Series No. 546, WHO,
Geneva.
9
2. CLASSIFICATION OF CARCINOGENS FQR THE
£2iIös|_ö?_LECllLÄ2I9ä
10
proportion of malignancies and the ^steepness of the slope of the
dose-response curve. However, the carcinogenic potency of a
chemical is not a characteristic independent of the «xperimental
condition nor of biological parameters. Animal species, strain of
animals, sex, age at start of exposure, nutritional factors,
enzymatic pattern, immunological factors, routes or types of
administration are among those factors influencing the dose-
response. Thus, 2-nap'hthylamine seems, for instance, to be a
carcinogen of lower potency for rats and rabbits than for dogs and
humans. Some experimental highly active carcinogens, like
methylnitrosourea and dietbylnitrosourea, occur in environments
where the establishment of their risk in occupational handling is
difficult. The listing of carcinogens as high potent/low potent
carcinogens, implying different levels of legislative action
according to potency, may thus lead either to workers being exposed
to potential carcinogenic hazards or to unnecessary stringent
legislation.
A listing of carcinogens occurring in the occupational
environment could be structured according to technological criteria.
This may refer either to the technical necessity of using a specific
substance having a carcinogenic action for a given technological
process, or to the degree of exposure to a carcinogen under normal
operating conditions. Both approaches may result in a list of
prohibited substances. There is no doubt that some potential
carcinogens used by industry could be dispensed with, although the
economic impact of the withdrawal of such potential carcinogens
varies from country to country. There is also no doubt that many
carcinogenic substances can be substituted by other non-carcinogenic
compounds or by compounds known to present less risk in a carefully
controlled work environment, as estimated in reliable epidemio-
logical studies.
In the recommendations which follow, carcinogenic chemicals,
physical agents and processes are classified on the basis of their
estimated potential for inducing cancer in working populations.
Therefore, a number of factors are combined in the assessment. It
is not proposed that the listings as shown in Appendix 1 are all-
inclusive, but they are rather an attempt to identify the risks for
which, in the view of the ILO Panel of Consultants, sufficient
information is available at the present time. It is anticipated
that as more information becomes available on these and other
problems, the listings will be modified and appropriate additions
and/or deletions made.
Specific recommendations have not been made as to the
appropriate course of action to be taken by governments or
industries to arrive at the degree of control recommended for each
category. Depending on a number of complex individual factors,
these may include banning the use of certain chemicals, the need to
obtain special authorisation for use and/or the establishment of
levels of exposure based on current control technology.
In cases where the competent authority has power to deliver
special authorisation for the production or use of specified
carcinogenic substances, such authorisation should stipulate the
obligation to apply strict preventive measures. These should
include such appropriate technical, hygiene and personal protective
measures that would ensure a satisfactory protection; the medical
supervision, biological tests or other investigations to be carried
out; the records to be maintained and the professional
qualifications of those dealing with the supervision of exposure to
the substances in question.
11
Due to the paucity of epidemiological data, uncertainties in
extrapolating animal data to human exposures, and the conceptual
difficulty in formulating acceptable degrees of risk, it would
appear particularly difficult to recommend "safe" levels of exposure
for carcinogenic substances at this time. There is, however, from
a practical point of view* a clear need to provide guidance for
cases in which the production or use of carcinogenic substances
cannot be dispensed with, in particular where they also present
other types of risks, such as intoxication, explosion, etc. One way
to cope with this need at the present time is to prescribe for
certain carcinogens the "technical reference concentrations"
referred to above, whose role is to give guidance in the
implementation of technical preventive measures designed to reduce
to a minimum the exposure to these substance's. This has been done
in certain national lists, where provisional limit values have been
assigned to less dangerous carcinogens.
12
3. PREVENTIVE MEASURES
3.1 Ggneral_ErincÍEles
production;
laboratory operations;
13
repairs and preventive maintenance;
incidents.
Sasic_Hrinci£le
Technical preventive measures should form an integral part of
all work in which carcinogens are encountered or night be
encountered, and before commencing or continuing operations it
should be ensured that these measures are effectively implemented.
Their implementation should be such as to render other measures
unnecessary and taken only on precautionary grounds.
Substitution
Wherever possible, products known to be carcinogenic in man or
likely to be carcinogenic in man should be replaced by other
products. Nevertheless, it must be proved that these substitution
products constitute a significantly lower health hazard from all
toxicological points of view.
Where information is lacking on the health hazards of a given
product, for example with new products, literature studies and
experimental research should be carried out at the appropriate time
with particular reference to potential carcinogenic action.
Special studies
A decision to utilise a process in which a carcinogen is
employed or during which a carcinogen- may occur, entails a "special
study". Such special studies are aimed at minimising the duration
of the dangerous operations and clearly identifying these operations
for the information of those in charge of the plant. They also
provide the necessary detail regarding the physical nature of the
hazard, and a complete range of technical data for different stages:
temperatures, pressures, etc.
1U
Technological study
The installation is then designed on the basis of the specific
data provided by the above special study in such a way that the
eguipnent gives rise to no external contaoination. The over-all and
detailed phases of the technological study should deal in particular
with:
the plant location (prenises with permanent ventilation
equipment or open-air installations) ;
the design of the plant itself, its equipment, the choice of
materials, etc., making allowance for any subsequent
maintenance or repair work which might entail a substantial
hazard (for example, foresee the likelihood of the workers
being involved in such operations having to wear complete
airtight "divers" suits with maybe bulky, self-contained
respirators), special gaseous, liquid or solid effluent
circuits sealed off from the environment, and the special
processing of effluents to ensure purification prior to waste
disposal, and the development of decontamination procedures
for spillage;
safety and rescue procedures to minimise the risk of
contamination and to deal with possible breakdowns or
failures;
suitable washing facilities (washbasins with a regular soap
supply, disposable drying materials or hot-air dryers) and
immediate decontamination facilities (emergency showers).
Operating instructions
Procedures should be established in relation to the potential
hazards. They should be. expressed clearly in language readily
understandable so as to exclude all improvisation. They should be
designed in such a way tha.t, during potentially hazardous
operational phases, the workers are not burdened by time limits.
Possible incidents should be foreseen and simple precautionary
measures indicated; if necessary, provision should be made for
interruption of the process which can then be recommenced after a
break.
15
As far as possible, maintenance and repair work should always
be entrusted tò the same workers who will, consequently, acquire
intimate knowledge of the plant and the work itself, become well
aware of the hazards and the safety measures and, moreover, be
subject to specific medical supervision.
Working_çlothes
Working clothes specially suited to the potential hazard
should be given to workers engaged in operations involving potential
exposure to carcinogenic substances. The type of clothing will
depend on the nature of the product, its physical properties, its
consistency, etc. Workers may receive complete sets of clothing
including underclothes and footwear or may, for example, receive
only overalls. The intervals at which this clothing is changed will
depend on the foregoing properties.
An adequate stock of clean replacement clothing should be
available to ensure correct laundering and immediate replacement in
the event of soiling. The intervals at which this clothing is
washed will depend on the severity of the potential hazard and the
properties of the product. Special provision should be made for
collecting and laundering contaminated clothing. If necessary the
clothing may undergo special pre-treatment and then be washed
separately from the rest of the working clothes in the plant.
Before evacuation into the general sewage system, the effluents from
this treatment may be required to undergo a purification process to
remove the product in question.
Changing rooms
The changing rooms for these employees should be separate from
the general changing rooms and their design related to the potential
hazard. In general, they should be divided into three consecutive
sections: town-clothing changing rooms, showers, work-clothing
changing rooms, so that, at the end of the shift, there is no
contact between the working clothes, which are all left in the work
changing room in special containers where necessary, and the town-
clothing; employees put on their town-clothes only after compulsory
showers. Each employee should systematically be provided with
suitable washing materials with clean towels daily.
16
should be located at a suitable distance from the workplace. Before
enterin-g these mess rooms, workers should be required to wash their
hands carefully and to put on an overall to cover their working
clothes. Should the nature of the carcinogen make it necessary,
steps should be taken to prevent other possible causes of
contamination (prohibition of smoking in the plant for example).
3. <J Emergencies
Detailed instructions should be laid down describing the
action to be taken in the event of an incident such as a plant
breakdown or other failure which may lead to contamination with
potent carcinogens. These instructions should specify, in
particular, the evacuation of all non-essential workers who night be
subject to contamination.
Wherever possible, after arresting the escape of the
contaminant, subsequent operations should be carried out under
strict control, applying all the necessary safety measures. Such
precautions should be of the highest order and may require the use
of special equipment and clothing.
Following accidental contamination or work on an apparatus
which may have caused contamination, systematic decontamination
should be immediately carried out on:
workers)
) where necessary even before clothing is removed
clothes)
equipment
premises.
In such circumstances, special checks should also be carried out
(see section Hf.
17
4. EXPOSURE HONITORING
A£§â§_to_b,e_monitored
(a) fixed point monitoring (valves, gaskets, etc., where leaks may
develop) ;
Analytical techniques
18
positive, sampling should be regularly repeated in the manner
specified in the preceding paragraph, whilst at the same time the
cause of the contamination should be sought.
with_regard_to_açtion
Within a minimum lapse of time as reguired for carrying out
the analyses, the results of the workplace checks should be sent to
those responsible for information and, as necessary, for
implementation of corrective action.
Reçordin2_of_monitorin2_results
These results should be kept in one or more registers or card
indexes by both the head of service in question and by the works'
medical officer. Extracts may be transferred to other special
documents such as personal exposure records, work operations records
or medical records. Should a department terminate its activities,
these registers or monitoring records should be kept by the plant
management. Should the plant terminate its activities, these
registers or records should be kept by the corresponding management
offices of the company. If the company should go out of business,
the records should be transmitted to the appropriate agency of the
competent government authority.
Information of workers
The results of monitoring checks should be made available to
the workers directly concerned; they should also be informed
directly of any results indicating abnormal contamination and of
measures taken or to be taken to prevent recurrences. Such
information should also be made available to members of the safety
and health committee of the enterprise.
i». 2 Biologiçal_monitorina
Where carcinogenic agents are used, working conditions should
be evaluated in regard to hazards and decisions made as to the best
techniques available for evaluating personal contamination. This
may be done through the determination of the carcinogenic substances
in question or their metabolites, as the case may be, in samples of
urine, blood, stools and expired air.
19
Biological, procedures
It should be ascertained whether suitable procedures have been
published in the literature. If not, information should be sought
fron the laboratories mentioned above that carry out the workplace
monitoring, or from appropriate authorities,. international
organisations or universities in order to find out if techniques are
available.
Examinations shoul'd be carried out by a qualified laboratory
to be designated with the agreement of the industrial medical
officer, and which may or may not form part of the plant or the
company.
Monitoring periodicity
Based on the nature of the work done by each person in
question, a decision should be taken by, or in consultation with,
the industrial medical officer as to frequency of testing. This
should be reconsidered in case of any modification of processes or
introduction of new processes. In the event of abnormal
contamination revealed by environmental samples or in the event of
a technical accident or incident, special personal measurements
should be carried out systematically. In addition, the medical
officer should decide on any personal checks he deems useful.
Interpretation of results
with .regard to action
The data concerning the results of the medical examinations
and the biological tests should be normally covered by medical
secrecy. However, the detection of abnormal exposure or
contamination should lead to a prompt search for the causative
factors, and to the implementation of technical modifications or
other measures, such as improved personal hygiene, needed to rectify
the situation.
20
5. PERSOHHEL ADMINISTRATION
5.2 Informing_workers
Personnel assigned directly or occasionally to this kind of
work should be adeguately informed as to the nature of specific
hazard, the reasons for the safety measures applied, the effects of
work procedures and the form of medical supervision. This
information shall include, but not be limited to, the carcinogenic
risk. Other hazardous properties such as explqsiveness,
flammability, acute, chronic and other toxic effects should also be
adeguately identified.
A briefing should take place before assignment and regularly
thereafter. It should include essential basic data on signing-on;
a regular repetition of the initial brief and presentation of any
newly available information; the results of measurements of group
contamination and, individually, the results of measurements of
personal exposure (where these measurements are possible), together
with • any comments necessary to draw relevant conclusions; and
details of any incidents that may have occurred.
5. 3 La bour_t ur_nover
The competence needed for normal operations and for handling
incidents can be best achieved if the workforce is stable; this is
also a prereguisite of adeguate medical supervision. To comply with
the provisions of the ILO Recommendation concerning prevention and
control of occupational hazards caused by carcinogenic substances
and agents regarding the reduction of a number of workers exposed to
carcinogens, it is desirable to have as low a labour turnover as
possible. These considerations refer egually to intermittent
workers-such as maintenance personnel, as well as to workers
employed by external contractors where these are necessary. It is
to be noted that the availability of a sufficient number of
competent and well-trained workers has a bearing on the safe
operation of an installation. The same considerations apply to
workers employed by external contractors.
21
5. 4 Lists of workers
Lists of workers directly assigned to this type of work or
employed occasionally on such jobs should be drawn up and kept as
indicated under section 7.1.
22
6
• fiIEi£*L_SöPERVISiON
6.2 Infor§ation_to_be_su££lied_to
the responsible physician
23
QEÊ£âÎi2fiâi_iSf2£SâU2û
The medical officer should be immediately informed of any
incident, breakdown or failure or any unusual operation that might
result in abnormal exposure in order that such information may be
recorded for the individual worker.
Ifi£°£lâtion_ço^ç.exnin3_th^_worjçers
The medical officer should receive routine information on
absences from work due to illness amongst workers in these work-
places. workers should also have access to the medical officer to
report symptoms or signs of ill-health. The medical officer should
also attempt to record information as to employee's use of tobacco,
alcohol and prolonged medication. workers should not return to
these posts after illness until they have undergone a medical
examination and the approval of the medical officer has been
obtained.
6. 3 âssig_nœent_to_s£eçif ied_work£iâçes
No worker should be assigned to a new post nor continue to
work in a specified workplace, nor resume his work in such places
after an absence due to illness, unless he produces a fitness
certificate delivered by the industrial medical officer.
2H
7. REGISTERS AND RECORDING
25
7.2 Sedical_fîles
The following personal data should be systematically attached
to the normal medical records of each person on the lists drawn up
in accordance with the previous paragraph; they may either be added
to the normal medical record or be contained in a special medical
record appended to the normal file:
data about assignment, and workplace;
dates, duration and causes of absences;
dates and results of personal exposure measurements;
dates and results of specific medical supervision and
detection examinations.
A document should collate the results of the specific
individual examinations to provide material for an over-all study.
The results of various group measurements should be filed by
the medical officer and kept in a fora in which they can be used for
each individual case or for an over-all study.
These documents should be drawn up under the responsibility of
the medical officer and kept for at least 30 years. Should the
plant close down, they should be sent to the company's central
medical service, due consideration being paid to normal medical
secrecy. In the event of the company ceasing to trade, the records
should be sent to the appropriate agency of the competent authority.
A copy of these various personal medical documents should be given
to the workers in question on request.
26
APPENDIX 1»
» The indicative lists given above have been drawn up by the ILO
Panel of Consultants as a guide to implementation of the preventive
measures referred to in the present document. A number of national
lists of toxic substances for which exposure limits are prescribed
make reference to carcinogenic substances. The lists will be found
together with complementary information in "Occupational exposure
limits for airborne toxic substances" (ILO, Occupational Safety and
Health_Series No.37).
27
GRODP 3 - Exposure should be kept to a mininun through the use of the
most feasible and applicable controls
inorganic arsenic
nickel carbonyl
4,4*-methylene-bis-o-chloraniline (HOCA)
dimethyl sulfate
3,3'-dichlorobenzidine
o-tolidine
dianisidine
ethylenimine
ethylene thiourea
28
APPENDIX 2
lLP_international instruments
Convention 139
Article 2
1. Each Member which ratifies this Convention shall make every effort to have
carcinogenic substances and agents to which workers may be exposed in the course of
their work replaced by non-carcinogenic substances or agents or by less harmful
29
substances or agents; in the choice of substitute substances or agents account shall be
taken of their carcinogenic, toxic and other properties.
2. The number of workers exposed to carcinogenic substances or agents and the
duration and degree of such exposure shall be reduced to the minimum compatible
with safety.
Article 3
Each Member which ratifies this Convention shall prescribe the measures to be
taken to protect workers against the risks of exposure to carcinogenic substances or
agents and shall ensure the establishment of an appropriate system of records.
Article 4
Each Member which ratifies this Convention shall take steps so that workers who
have been, are, or are likely to be exposed to carcinogenic substances or agents are
provided with all the available information on the dangers involved and on the
measures to be taken.
Article 5
Each Member which ratifies this Convention shall take measures to ensure that
workers are provided with such medical examinations or biological or other tests or
investigations during the period of employment and thereafter as are necessary to
evaluate their exposure and supervise their state of health in relation to the occupa-
tional hazards.
Article 6
Each Member which ratifies this Convention—
(a) shall, by laws or regulations or any other method consistent with national
practice and conditions and in consultation with the most representative organisa-
tions of employers and workers concerned, take such steps as may be necessary
to give effect to the provisions of this Convention;
(b) shall, in accordance with national practice, specify the persons or bodies on
whom the obligation of compliance with the provisions of this Convention rests;
(c) undertakes to provide appropriate inspection services for the purpose of super-
vising the application of this Convention, or to satisfy itself that appropriate
inspection is carried out.
Article 7
The formal ratifications of this Convention shall be communicated to the Director-
General of the International Labour Office for registration.
Article 8
1. This Convention shall be binding only upon those Members of the Interna-
tional Labour Organisation whose ratifications have been registered with the Director-
General.
2. It shall come into force twelve months after the date on which the ratifications
of two Members have been registered with the Director-General.
3. Thereafter, this Convention shall come into force for any Member twelve
months after the date on which its ratification has been registered.
30
Artide 9
1. A Member which has ratified this Convention may denounce it after the
expiration of ten years from the date on which the Convention first comes into force,
by an act communicated to the Director-General of the International Labour Office
for registration. Such denunciation shall not take effect until one year after the date
on which it is registered.
2. Each Member which has ratified this Convention and which does not, within
the year following the expiration of the period of ten years mentioned in the preceding
paragraph, exercise the right of denunciation provided for in this Article, will be
bound for another period of ten years and, thereafter, may denounce this Convention
at the expiration of each period of ten years under the terms provided for in this
Article.
Article 10
1. The Director-General of the International Labour Office shall notify all
Members of the International Labour Organisation of the registration of all ratifica-
tions and denunciations communicated to him by the Members of the Organisation.
2. When notifying the Members of the Organisation of the registration of the
second ratification communicated to him, the Director-General shall draw the
attention of the Members of the Organisation to the date upon which the Convention
will come into force.
Article 11
The Director-General of the International Labour Office shall communicate to
the Secretary-General of the United Nations for registration in accordance with
Article 102 of the Charter of the United Nations full particulars of all ratifications
and acts of denunciation registered by him in accordance with the provisions of the
preceding Articles.
Article 12
At such times as it may consider necessary the Governing Body of the Interna-
tional Labour Office shall present to the General Conference a report on the working
of this Convention and shall examine the desirability of placing on the agenda of
the Conference the question of its revision in whole or in part.
Article 13
1. Should the Conference adopt a new Convention revising this Convention in
whole or in part, then, unless the new Convention otherwise provides—
(a) the ratification by a Member of the new revising Convention shall ipso jure
involve the immediate denunciation of this Convention, notwithstanding the
provisions of Article 9 above, if and when the new revising Convention shall
have come into force;
(b) as from the date when the new revising Convention comes into force this Con-
vention shall cease to be open to ratification by the Members.
2. This Convention shall in any case remain in force in its actual form and content
for those Members which have ratified it but have not ratified the revising Convention.
Article 14
The English and French versions of the text of this Convention are equally
authoritative.
31
Recommendation 147
I. GENERAL PROVISIONS
33
4. (1) Employers should make every effort to use work processes which do not
cause the formation, and particularly the emission in the working environment,
of carcinogenic substances or agents, as main products, intermediates, by-products,
waste products or otherwise.
(2) Where complete elimination of a carcinogenic substance or agent is not pos-
sible, employers should use all appropriate measures, in consultation with the
workers and their organisations and in the light of advice from competent sources,
including occupational health services, to eliminate exposure or reduce it to a mini-
mum in terms of numbers exposed, duration of exposure and degree of exposure.
(3) In cases to be determined by the competent authority, the employer should
make arrangements for the systematic surveillance of the duration and degree of
exposure to carcinogenic substances or agents in the working environment.
(4) Where carcinogenic substances or agents are transported or stored, all appro-
priate measures should be taken to prevent leakage or contamination.
5. Workers and others involved in occupational situations in which the risk of
exposure to carcinogenic substances or agents may occur should conform to the
safety procedures laid down and make proper use of all equipment furnished for
their protection or the protection of others.
34
(2) The competent authority should further establish the criteria for determin-
ing the degree of exposure to the substances or agents in question, and where appro-
priate should specify levels as indicators for surveillance of the working environment
in connection with the technical preventive measures required.
10. The competent authority should keep the determination of carcinogenic sub-
stances and agents made in pursuance of this Part of this Recommendation up
to date.
35
IV. INFORMATION AND EDUCATION
16. (1) The competent authority should promote epidemiological and other
studies and collect and disseminate information relevant to occupational cancer
risks, with the assistance as appropriate of international and national organisations,
including organisations of employers and workers.
(2) It should endeavour to establish the criteria for determining the carcino-
genicity of substances and agents.
17. The competent authority should draw up suitable educational guides for both
employers and workers on substances and agents liable to give rise to occupational
cancer.
18. Employers should seek information, especially from the competent authority,
on carcinogenic hazards which may arise with regard to any substance or agent
introduced or to be introduced into the undertaking; when a carcinogenic potential
is suspected, they should decide in consultation with the competent authority on the
additional studies to be carried out.
19. Employers should ensure that in the case of any substance or agent which
is carcinogenic there is at the workplace an appropriate indication to any worker
who may be liable to exposure of the danger which may arise.
20. Employers should instruct their workers before assignment and regularly
thereafter, as well as on introduction of a new carcinogenic substance or agent,
on the dangers of exposure to carcinogenic substances and agents and on the
measures to be taken.
21. Employers' and workers' organisations should take positive action to carry
out programmes of information and education with regard to the hazards of occupa-
tional cancer, and should encourage their members to participate fully in programmes
of prevention and control.
V. MEASURES OF APPLICATION
36